Live attenuated virus vaccines: After treatment with immunoglobulins, the efficacy of live attenuated vaccines, such as measles, mumps, rubella and chickenpox vaccines, may be impaired for a period of at least 6 weeks and up to 3 months. An interval of 3 months should elapse before vaccination with live attenuated vaccines. In the case of measles vaccinations, the decrease in efficacy may persist for up to a year. Patients given measles vaccine should therefore have their antibody status checked.
Paediatric population: Although limited data is available, it is expected that the same interactions may occur in the paediatric population.